These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3924061)

  • 21. Auranofin (Ridaura).
    Med Lett Drugs Ther; 1985 Oct; 27(699):89-90. PubMed ID: 3932827
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long-term tolerance of oral gold therapy in rheumatoid arthritis. Frequency and intensity of undesirable side effects].
    Goebel KM; Storck U
    Schweiz Med Wochenschr; 1985 Dec; 115(49):1775-7. PubMed ID: 3937234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: an X-ray analysis.
    Larsen A; Horton J; Howland C
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():97-104. PubMed ID: 6432419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roentgenographic findings during auranofin treatment.
    Gofton JP; O'Brien W
    Am J Med; 1983 Dec; 75(6A):142-4. PubMed ID: 6419597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Searching for oral gold--for some arthritis patients.
    Gunby P
    JAMA; 1980 Nov; 244(18):2022, 2027. PubMed ID: 6776295
    [No Abstract]   [Full Text] [Related]  

  • 26. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC; Osborn TG
    Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotoxicity following a very high dose of oral gold (auranofin).
    Gambari P; Ostuni P; Lazzarin P; Tavolato B; Todesco S
    Arthritis Rheum; 1984 Nov; 27(11):1316-7. PubMed ID: 6093822
    [No Abstract]   [Full Text] [Related]  

  • 28. [Auranofin in the treatment of chronic polyarthritis. Results of an open multicenter study].
    Siegmeth W
    Wien Klin Wochenschr Suppl; 1984; 156():27-33. PubMed ID: 6442053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind study.
    van Riel PL; van de Putte LB; Gribnau FW; Macrae KD
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():51-6. PubMed ID: 6432414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gold concentrations and toxicity during oral gold treatment with auranofin.
    Sharma RP; Smillie J; Palmer DG
    Pharmacology; 1985; 30(2):115-20. PubMed ID: 3919401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Worldwide clinical experience with auranofin.
    Morris RW; Cole DS; Horton J; Heuer MA; Pietrusko RG
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():105-11. PubMed ID: 6432408
    [No Abstract]   [Full Text] [Related]  

  • 32. [Basic therapy of rheumatoid arthritis with auranofin].
    Goebel KM
    Dtsch Med Wochenschr; 1985 Jan; 110(2):64-5. PubMed ID: 3917898
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT
    J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J; Davis P; Owen ET
    J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 36. Auranofin: dose-related risk to benefit.
    Weiss TE
    Am J Med; 1983 Dec; 75(6A):128-32. PubMed ID: 6419594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An oral formulation of gold for the treatment of rheumatoid arthritis.
    Meyers OL; Klemp P
    S Afr Med J; 1981 Jun; 59(27):969-71. PubMed ID: 6787721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long term auranofin treatment in rheumatoid arthritis.
    Godfrey N; Lorber A
    J Rheumatol; 1985 Jun; 12(3):620-2. PubMed ID: 3930723
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs recently released in Belgium.
    Harvengt C
    Acta Clin Belg; 1984; 39(4):261-4. PubMed ID: 6440386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.